- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Radiologically Isolated Syndrome.
Displaying page 1 of 1.
| EudraCT Number: 2018-000736-10 | Sponsor Protocol Number: BCG-RIS-01 | Start Date*: 2019-01-24 | |||||||||||
| Sponsor Name:FONDAZIONE ITALIANA SCLEROSI MULTIPLA ONLUS | |||||||||||||
| Full Title: “Bacille Calmette-Guérin (BCG) vaccine In Radiologically Isolated Syndrome (Ris)” | |||||||||||||
| Medical condition: Radiologically Isolated Syndrome (Ris) | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Trial now transitioned) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2008-005041-33 | Sponsor Protocol Number: MAG111539 | Start Date*: 2009-07-27 | |||||||||||
| Sponsor Name:GlaxoSmithKline Research & Development Ltd | |||||||||||||
| Full Title: A Single-Blind Study of the Safety, Pharmacokinetics and Pharmacodynamics of Escalating Repeat Doses of GSK249320 in Patients With Stroke. | |||||||||||||
| Medical condition: Patients with Stroke. | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2019-004108-37 | Sponsor Protocol Number: CC-99677-AS-001 | Start Date*: 2021-07-09 | |||||||||||
| Sponsor Name:Celgene Corporation | |||||||||||||
| Full Title: A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of CC-99677 in Subjects with Active Ankylosing Spondylitis | |||||||||||||
| Medical condition: Ankylosing Spondylitis | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) CZ (Prematurely Ended) PL (Prematurely Ended) RO (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2012-004494-23 | Sponsor Protocol Number: MAG104615 | Start Date*: 2013-03-18 | |||||||||||
| Sponsor Name:GlaxoSmithKline Research & Development Ltd | |||||||||||||
| Full Title: Study MAG104615, a Proof of Concept Study for GSK249320 versus placebo in Stroke Patients | |||||||||||||
| Medical condition: Stroke | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Prematurely Ended) DE (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.